Xiangjiang Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiangjiang Shi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Wang Xu
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
3 shared publicationsJian Yang
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
2 shared publicationsJianbo Yue
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
2 shared publicationsJiang Li
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
2 shared publicationsJin Luo
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
2 shared publicationsLin He
Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang, China
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in Scientific Reports
Left atrial function and stiffness in HFpEF patients with and without paroxysmal atrial fibrillation: associations with PAF and clinical outcomes
- 16 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessLeft atrial function and stiffness in HFpEF patients with and without paroxysmal atrial fibrillation: associations with PAF and clinical outcomes
- Open Access
- 27 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Impaired left atrial function increases the risk of incident atrial fibrillation and heart failure with preserved ejection fraction in hypertensive patients
Left atrial (LA) function has emerged as an important marker of LA compliance and has been associated with adverse outcomes in patients with heart failure
- 27 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessImpaired left atrial function increases the risk of incident atrial fibrillation and heart failure with preserved ejection fraction in hypertensive patients
Left atrial (LA) function has emerged as an important marker of LA compliance and has been associated with adverse outcomes in patients with heart failure
- Open Access
- 28 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Integrated analysis of m6A regulator mediated RNA methylation and key immune related genes in ischemic stroke
The role of RNA N6-methyladenosine (m6A) modifications in modulating the immune microenvironment during ischemic stroke (IS) pathogenesis remains poorly characterized. This investigation systematically explores m6A-mediated immune regulation in IS and identifies critical immune-related biomarkers. Transcriptomic profiles from 108 IS samples were analyzed to discern m6A regulatory patterns. Single-sample gene set enrichment analysis (ssGSEA) and gene set variation analysis (GSVA) quantified immune cell infiltration and pathway activity across IS subtypes and controls. Weighted gene co-expression network analysis (WGCNA) identified m6A-associated gene modules. Two complementary machine learning approaches were applied to identify the key immune-related genes implicated in IS pathogenesis. The robustness of these findings was subsequently confirmed through a comprehensive meta-analysis integrating six independent datasets. Eight dysregulated m6A regulators distinguished IS from controls. Unsupervised clustering delineated two distinct m6A modification patterns (Clusters A/B) with divergent immune landscapes: Cluster B exhibited heightened infiltration of natural killer cells, eosinophils, and activated CD4 T cells, coupled with IL6/JAK/STAT3 pathway activation, whereas Cluster A demonstrated enrichment of immature dendritic cells and monocytes, alongside oxidative phosphorylation signaling. WGCNA identified a conserved immune-related module (black module, r = 0.68 with Cluster B) containing 322 co-expressed genes. Cross-validation by machine learning nominated five candidate biomarkers (ABCA1, CPD, PRRG4, WDR46, C19orf24) showing consistent expression trends in internal validation cohorts (Control vs. IS and Cluster A vs. B). External validation via meta-analysis confirmed WDR46 as a protective factor against IS susceptibility (odds ratio [OR] = 0.74, 95% confidence interval [CI]: 0.57–0.97), while CPD (OR = 1.46, 95% CI: 1.01–2.10) and ABCA1 (OR = 1.57, 95% CI: 1.12–2.22) were significantly associated with increased IS susceptibility, establishing their roles as risk genes. Subsequent RT-qPCR analysis in clinical samples further validated the results of the aforementioned external validation. Moreover, ROC analysis revealed an AUC of 0.88 (95% CI: 0.82–0.94) for ABCA1, 0.82 (95% CI: 0.74–0.89) for WDR46, and 0.90 (95% CI: 0.84–0.96) for CPD. This study establishes m6A epitranscriptomic remodeling as a pivotal orchestrator of immune microenvironment heterogeneity in IS. The identification of ABCA1, CPD, and WDR46 as promising biomarkers not only enhances the potential for precise diagnosis but also provides actionable targets for immunomodulatory therapy in IS.
- 28 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Open AccessIntegrated analysis of m6A regulator mediated RNA methylation and key immune related genes in ischemic stroke
The role of RNA N6-methyladenosine (m6A) modifications in modulating the immune microenvironment during ischemic stroke (IS) pathogenesis remains poorly characterized. This investigation systematically explores m6A-mediated immune regulation in IS and identifies critical immune-related biomarkers. Transcriptomic profiles from 108 IS samples were analyzed to discern m6A regulatory patterns. Single-sample gene set enrichment analysis (ssGSEA) and gene set variation analysis (GSVA) quantified immune cell infiltration and pathway activity across IS subtypes and controls. Weighted gene co-expression network analysis (WGCNA) identified m6A-associated gene modules. Two complementary machine learning approaches were applied to identify the key immune-related genes implicated in IS pathogenesis. The robustness of these findings was subsequently confirmed through a comprehensive meta-analysis integrating six independent datasets. Eight dysregulated m6A regulators distinguished IS from controls. Unsupervised clustering delineated two distinct m6A modification patterns (Clusters A/B) with divergent immune landscapes: Cluster B exhibited heightened infiltration of natural killer cells, eosinophils, and activated CD4 T cells, coupled with IL6/JAK/STAT3 pathway activation, whereas Cluster A demonstrated enrichment of immature dendritic cells and monocytes, alongside oxidative phosphorylation signaling. WGCNA identified a conserved immune-related module (black module, r = 0.68 with Cluster B) containing 322 co-expressed genes. Cross-validation by machine learning nominated five candidate biomarkers (ABCA1, CPD, PRRG4, WDR46, C19orf24) showing consistent expression trends in internal validation cohorts (Control vs. IS and Cluster A vs. B). External validation via meta-analysis confirmed WDR46 as a protective factor against IS susceptibility (odds ratio [OR] = 0.74, 95% confidence interval [CI]: 0.57–0.97), while CPD (OR = 1.46, 95% CI: 1.01–2.10) and ABCA1 (OR = 1.57, 95% CI: 1.12–2.22) were significantly associated with increased IS susceptibility, establishing their roles as risk genes. Subsequent RT-qPCR analysis in clinical samples further validated the results of the aforementioned external validation. Moreover, ROC analysis revealed an AUC of 0.88 (95% CI: 0.82–0.94) for ABCA1, 0.82 (95% CI: 0.74–0.89) for WDR46, and 0.90 (95% CI: 0.84–0.96) for CPD. This study establishes m6A epitranscriptomic remodeling as a pivotal orchestrator of immune microenvironment heterogeneity in IS. The identification of ABCA1, CPD, and WDR46 as promising biomarkers not only enhances the potential for precise diagnosis but also provides actionable targets for immunomodulatory therapy in IS.
- Open Access
- 8 July 2025
- Vol. 15 (1) , 24365
Integrating radiomic texture analysis and deep learning for automated myocardial infarction detection in cine-MRI.
Robust differentiation between infarcted and normal myocardial tissue is essential for improving diagnostic accuracy and personalizing treatment in myocardial infarction (MI). This study proposes a hybrid framework combining radiomic texture analysis with deep learning-based segmentation to enhance MI detection on non-contrast cine cardiac magnetic resonance (CMR) imaging.The approach incorporates radiomic features derived from the Gray-Level Co-Occurrence Matrix (GLCM) and Gray-Level Run Length Matrix (GLRLM) methods into a modified U-Net segmentation network. A three-stage feature selection pipeline was employed, followed by classification using multiple machine learning models. Early and intermediate fusion strategies were integrated into the hybrid architecture. The model was validated on cine-CMR data from the SCD and Kaggle datasets.Joint Entropy, Max Probability, and RLNU emerged as the most discriminative features, with Joint Entropy achieving the highest AUC (0.948). The hybrid model outperformed standalone U-Net in segmentation (Dice = 0.887, IoU = 0.803, HD95 = 4.48 mm) and classification (accuracy = 96.30%, AUC = 0.97, precision = 0.96, recall = 0.94, F1-score = 0.96). Dimensionality reduction via PCA and t-SNE confirmed distinct class separability. Correlation coefficients (r = 0.95-0.98) and Bland-Altman plots demonstrated high agreement between predicted and reference infarct sizes.Integrating radiomic features into a deep learning segmentation pipeline improves MI detection and interpretability in cine-CMR. This scalable and explainable hybrid framework holds potential for broader applications in multimodal cardiac imaging and automated myocardial tissue characterization.
- 8 July 2025
- Vol. 15 (1) , 24365
Open AccessIntegrating radiomic texture analysis and deep learning for automated myocardial infarction detection in cine-MRI.
Robust differentiation between infarcted and normal myocardial tissue is essential for improving diagnostic accuracy and personalizing treatment in myocardial infarction (MI). This study proposes a hybrid framework combining radiomic texture analysis with deep learning-based segmentation to enhance MI detection on non-contrast cine cardiac magnetic resonance (CMR) imaging.The approach incorporates radiomic features derived from the Gray-Level Co-Occurrence Matrix (GLCM) and Gray-Level Run Length Matrix (GLRLM) methods into a modified U-Net segmentation network. A three-stage feature selection pipeline was employed, followed by classification using multiple machine learning models. Early and intermediate fusion strategies were integrated into the hybrid architecture. The model was validated on cine-CMR data from the SCD and Kaggle datasets.Joint Entropy, Max Probability, and RLNU emerged as the most discriminative features, with Joint Entropy achieving the highest AUC (0.948). The hybrid model outperformed standalone U-Net in segmentation (Dice = 0.887, IoU = 0.803, HD95 = 4.48 mm) and classification (accuracy = 96.30%, AUC = 0.97, precision = 0.96, recall = 0.94, F1-score = 0.96). Dimensionality reduction via PCA and t-SNE confirmed distinct class separability. Correlation coefficients (r = 0.95-0.98) and Bland-Altman plots demonstrated high agreement between predicted and reference infarct sizes.Integrating radiomic features into a deep learning segmentation pipeline improves MI detection and interpretability in cine-CMR. This scalable and explainable hybrid framework holds potential for broader applications in multimodal cardiac imaging and automated myocardial tissue characterization.
- Open Access
- 9 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Multiomics identification of ALDH9A1 as a crucial immunoregulatory molecule involved in calcific aortic valve disease
Mitochondrial dysfunction and immune cell infiltration play crucial yet incompletely understood roles in the pathogenesis of calcific aortic valve disease (CAVD). This study aimed to identify immune-related mitochondrial genes critical to the pathological process of CAVD using multiomics approaches. The CIBERSORT algorithm was employed to evaluate immune cell infiltration characteristics in CAVD patients. An integrative analysis combining weighted gene coexpression network analysis (WGCNA), machine learning, and summary data-based Mendelian randomization (SMR) was performed to identify key mitochondrial genes implicated in CAVD. Spearman’s rank correlation analysis was also performed to assess the relationships between key mitochondrial genes and infiltrating immune cells. Compared with those in normal aortic valve tissue, an increased proportion of M0 macrophages and resting memory CD4 T cells, along with a decreased proportion of plasma cells and activated dendritic cells, were observed in CAVD patients. Additionally, eight key mitochondrial genes associated with CAVD, including PDK4, LDHB, SLC25A36, ALDH9A1, ECHDC2, AUH, ALDH2, and BNIP3, were identified through the integration of WGCNA and machine learning methods. Subsequent SMR analysis, incorporating multiomics data, such as expression quantitative trait loci (eQTLs) and methylation quantitative trait loci (mQTLs), revealed a significant causal relationship between ALDH9A1 expression and a reduced risk of CAVD. Moreover, ALDH9A1 expression was inversely correlated with M0 macrophages and positively correlated with M2 macrophages. These findings suggest that increased ALDH9A1 expression is significantly associated with a reduced risk of CAVD and that it may exert its protective effects by modulating mitochondrial function and immune cell infiltration. Specifically, ALDH9A1 may contribute to the shift from M0 macrophages to anti-inflammatory M2 macrophages, potentially mitigating the pathological progression of CAVD. In conclusion, ALDH9A1 represents a promising molecular target for the diagnosis and treatment of CAVD. However, further validation through in vivo and n vitro studies is necessary to confirm its role in CAVD pathogenesis and therapeutic potential.
- 9 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Open AccessMultiomics identification of ALDH9A1 as a crucial immunoregulatory molecule involved in calcific aortic valve disease
Mitochondrial dysfunction and immune cell infiltration play crucial yet incompletely understood roles in the pathogenesis of calcific aortic valve disease (CAVD). This study aimed to identify immune-related mitochondrial genes critical to the pathological process of CAVD using multiomics approaches. The CIBERSORT algorithm was employed to evaluate immune cell infiltration characteristics in CAVD patients. An integrative analysis combining weighted gene coexpression network analysis (WGCNA), machine learning, and summary data-based Mendelian randomization (SMR) was performed to identify key mitochondrial genes implicated in CAVD. Spearman’s rank correlation analysis was also performed to assess the relationships between key mitochondrial genes and infiltrating immune cells. Compared with those in normal aortic valve tissue, an increased proportion of M0 macrophages and resting memory CD4 T cells, along with a decreased proportion of plasma cells and activated dendritic cells, were observed in CAVD patients. Additionally, eight key mitochondrial genes associated with CAVD, including PDK4, LDHB, SLC25A36, ALDH9A1, ECHDC2, AUH, ALDH2, and BNIP3, were identified through the integration of WGCNA and machine learning methods. Subsequent SMR analysis, incorporating multiomics data, such as expression quantitative trait loci (eQTLs) and methylation quantitative trait loci (mQTLs), revealed a significant causal relationship between ALDH9A1 expression and a reduced risk of CAVD. Moreover, ALDH9A1 expression was inversely correlated with M0 macrophages and positively correlated with M2 macrophages. These findings suggest that increased ALDH9A1 expression is significantly associated with a reduced risk of CAVD and that it may exert its protective effects by modulating mitochondrial function and immune cell infiltration. Specifically, ALDH9A1 may contribute to the shift from M0 macrophages to anti-inflammatory M2 macrophages, potentially mitigating the pathological progression of CAVD. In conclusion, ALDH9A1 represents a promising molecular target for the diagnosis and treatment of CAVD. However, further validation through in vivo and n vitro studies is necessary to confirm its role in CAVD pathogenesis and therapeutic potential.